Table 3.
Multivariable analysis of different foetal adverse pregnancy outcomes
Characteristics | B | P value | OR | 95% CI |
Foetal loss | ||||
Prepregnancy hypertension | 1.739 | <0.01 | 5.69 | 1.58 to 20.52 |
Disease flares during pregnancy | 1.054 | <0.01 | 2.87 | 1.45 to 5.69 |
Hypocomplementaemia-C3 | 1.552 | <0.01 | 4.72 | 2.47 to 9.02 |
aCL-IgM positivity | 1.421 | 0.02 | 4.14 | 1.24 to 13.84 |
Use of aspirin | −1.94 | <0.01 | 0.14 | 0.07 to 0.29 |
Premature birth | ||||
Disease flares during pregnancy | 0.872 | <0.01 | 2.39 | 1.48 to 3.84 |
HDP | 0.585 | 0.02 | 1.79 | 1.07 to 3.00 |
Use of Immunosuppressive agent | 0.694 | 0.03 | 2.00 | 1.04 to 3.86 |
Use of aspirin | −0.561 | 0.04 | 0.57 | 0.33 to 0.99 |
SGA | ||||
Multiple pregnancy | 2.085 | <0.01 | 8.04 | 1.81 to 35.71 |
Disease flare during pregnancy | 0.612 | 0.01 | 1.84 | 1.15 to 2.95 |
HDP | 0.914 | <0.01 | 2.49 | 1.49 to 4.15 |
Asphyxia neonatorum | ||||
Prepregnancy hypertension | 0.914 | <0.01 | 2.49 | 1.49 to 0.91 |
HDP, hypertensive disorders of pregnancy; SGA, small for gestational age.